Low-Dose Instillation Therapy with Bacille Calmette-Guérin Tokyo 172 Strain After Transurethral Resection: Historical Cohort Study

Urology

Volumn 71, Issue 6, 2008, Pages 1161-1165

  Yoneyama, Takahiro ^a   Ohyama, Chikara ^a   Imai, Atsushi ^a   Ishimura, Hirofumi ^a   Hagisawa, Shigeru ^a   Iwabuchi, Ikuya ^a   Mori, Kazuyuki ^a   Kamimura, Noritaka ^a   Koie, Takuya ^a   Yamato, Takashi ^a   Suzuki, Tadashi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BCG VACCINATION; BLADDER CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INSTILLATION; FEMALE; FOLLOW UP; HISTORY OF MEDICINE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLLAKISURIA; PRIORITY JOURNAL; PROPHYLAXIS; URETHRA SURGERY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 44649146617     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.11.080     Document Type: Article

References (17)

1. Morales A., Eidinger D., and Bruce A.W. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116 (1976) 180-183
2. Pagano F., Bassi P., Milani C., et al. A low dose bacillus Calmette-Guérin regimen in superficial bladder cancer therapy: is it effective?. J Urol 146 (1991) 32-35
3. Pagano F., Bassi P., Piazza N., et al. Improving the efficacy of BCG immunotherapy by dose reduction. Eur Urol 27 (1995) 19-22
4. Mack D., and Frick J. Low-dose bacillus Calmette-Guérin (BCG) therapy in superficial high-risk bladder cancer. Br J Urol 75 (1995) 185-187
5. Morales A., Nickel J.C., and Willson J.W. Dose-response of bacillus Calmette-Guérin in the treatment of superficial bladder cancer. J Urol 147 (1992) 1256-1258
6. Martinez-Pineiro J.A., Solsona E., Flores N., et al., Cooperative Group CUETO. Improving the safety of BCG immunotherapy by dose reduction. Eur Urol 27 (1995) 13-18
7. Yalcinkaya F., Kamis L., Ozteke O., et al. Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer. Int Urol Nephrol 30 (1998) 41-44
8. Martinez-Pineiro J.A., Flores N., Isorna S., et al. Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacilli Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancer. Br J Urol Int 89 (2002) 671-680
9. Hurle R., Losa A., Ranieri A., et al. Low dose Pasteur bacillus Calmette-Guérin regimen in stage T1, grade 3 bladder cancer therapy. J Urol 156 (1996) 1602-1605
10. Lebret T., Gaudez F., Herve J.M., et al. Low-dose instillations in the treatment of stage T1 grade 3 bladder tumours. Eur Urol 34 (1998) 67-72
11. Martinez-Pineiro J.A., Martinez-Pineiro L., Solsona E., et al. Has a 3-fold decreased dose of bacillus Calmette-Guérin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose?. Results of a prospective randomized trial. J Urol 174 (2005) 1242-1247
12. Ikeda N., Honda I., Yano I., et al. Bacillus Calmette-Guérin Tokyo 172 substrain for superficial bladder cancer: characterization and antitumor effect. J Urol 173 (2005) 1507-1512
13. Lamm D.L., van der Meijden P.M., Morales A., et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 147 (1992) 596-600
14. Shinka T., Matsumoto M., Ogura H., et al. Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Guérin: a long-term follow-up. Int J Urol 4 (1997) 139-143
15. Takashi M., Wakai K., Ohno Y., et al. Evaluation of low-dose intravesical bacillus Calmette-Guérin (Tokyo strain) therapy for superficial bladder cancer. Int Urol Nephrol 27 (1995) 723-733
16. Irie A., Uchida T., Yamashita H., et al. Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guérin for superficial bladder cancer recurrence. Int J Urol 10 (2003) 183-189
17. Droller MJ. Urothelial Tumors: American Cancer Society Atlas of Clinical Oncology. Hamilton, ON, BC Decker, 2004, pp 229-231.